» Articles » PMID: 9398843

Tumorigenesis and a DNA Repair Defect in Mice with a Truncating Brca2 Mutation

Overview
Journal Nat Genet
Specialty Genetics
Date 1997 Dec 17
PMID 9398843
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Germline mutation of the BRCA2 gene carries a high risk of developing breast cancer. To study the function of this gene, we generated a mutation in Brca2 in mice. Unlike other mutations in the Brca2 gene, which are lethal early in embryogenesis when homozygous, some of our homozygous mutant mice survive to adulthood. These animals have a wide range of defects, including small size, improper differentiation of tissues, absence of germ cells and the development of lethal thymic lymphomas. Fibroblasts cultured from BrcaZ-/-embryos have a defect in proliferation that may be mediated by over-expression of p53 and p21Waf1/CIP1. We show that Brca2 is required for efficient DNA repair, and our results suggest that loss of the p53 checkpoint may be essential for tumour progression triggered by mutations in BRCA2.

Citing Articles

BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality.

Khalizieva A, Moser S, Bouwman P, Jonkers J Genes Dev. 2024; 39(1-2):86-108.

PMID: 39510841 PMC: 11789497. DOI: 10.1101/gad.352083.124.


Complex Interplay between DNA Damage and Autophagy in Disease and Therapy.

Singh A, Ravendranathan N, Frisbee J, Singh K Biomolecules. 2024; 14(8).

PMID: 39199310 PMC: 11352539. DOI: 10.3390/biom14080922.


DMC1 and RAD51 bind FxxA and FxPP motifs of BRCA2 via two separate interfaces.

Miron S, Legrand P, Dupaigne P, van Rossum-Fikkert S, Ristic D, Majeed A Nucleic Acids Res. 2024; 52(12):7337-7353.

PMID: 38828772 PMC: 11229353. DOI: 10.1093/nar/gkae452.


BRCA2 promotes genomic integrity and therapy resistance primarily through its role in homology-directed repair.

Lim P, Zaman M, Feng W, Jasin M Mol Cell. 2024; 84(3):447-462.e10.

PMID: 38244544 PMC: 11188060. DOI: 10.1016/j.molcel.2023.12.025.


PP2A inhibition causes synthetic lethality in BRCA2-mutated prostate cancer models via spindle assembly checkpoint reactivation.

Wang J, Chen Y, Li S, Liu W, Zhou X, Luo Y J Clin Invest. 2023; 134(1).

PMID: 37934606 PMC: 10760972. DOI: 10.1172/JCI172137.